San Carlos, CA, United States of America

Daniel P Sutherlin

This inventor holds 55 USPTO granted patents and 24 published patent applications, plus 4 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Genentech, Inc., F. Hoffmann-La Roche Ag, Xenon Pharmaceuticals Inc.. Active years: 2002-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel P Sutherlin. Retrieved from https://idiyas.com/inventor/daniel-p-sutherlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 55 (Patent Applications = 24)

% Patents Active = 60.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 19 (Patent Applications = 28)

Average Co-Inventor Count = 7.4

ph-index = 10

Forward Citations = 338(Granted Patents)

Forward Citations (Not Self Cited) = 268(Dec 10, 2025)

Inventors with similar research interests:

Location History:

So. San Francisco, CA (US) (2007)
San Carlos, CA (US) (2002 - 2009)
Burlingame, CA (US) (2012 - 2017)
South San Francisco, CA (US) (2004 - 2021)

Company Filing History:

F. Hoffmann-La Roche Ag

patents

12 out of 110

Xenon Pharmaceuticals Inc.

Hoffmann-La Roche Inc.

where one patent can have more than one assignee

Years Active: 2002-2021

Loading Chart...

Areas of Expertise:

Pharmaceutical Compounds

PI3K Inhibitors

Therapeutic Compounds

Pyridyl Inhibitors

Benzamides

Hedgehog Signalling

Heterocyclic Compounds

Purine Compounds

Pyrazolopyridine

Bicyclic Pyrimidine

N-Substituted Benzamides

Benzopyran

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11203572 - Substituted benzamides and methods of use thereof (2021-12-21),

2. 11130726 - Therapeutic compounds and methods of use thereof (2021-09-28),

3. 11028075 - Therapeutic compounds and methods of use thereof (2021-06-08),

4. 10793550 - 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors (2020-10-06),

5. 10787446 - Therapeutic compounds and methods of use thereof (2020-09-29),

6. 10766858 - Substituted benzamides and methods of use thereof (2020-09-08),

7. 10457654 - Therapeutic compounds and methods of use thereof (2019-10-29),

8. 10179767 - Substituted benzamides and methods of use thereof (2019-01-15),

9. 10071957 - N-substituted benzamides and methods of use thereof (2018-09-11),

10. 9943519 - Pharmaceutical compounds (2018-04-17),

11. 9790183 - Pyridyl inhibitors of hedgehog signalling (2017-10-17),

12. 9771376 - N-substituted benzamides and methods of use thereof (2017-09-26),

13. 9694002 - Substituted benzamides and methods of use thereof (2017-07-04),

14. 9546164 - Substituted benzamides and methods of use thereof (2017-01-17),

15. 9487533 - Phosphoinositide 3-kinase inhibitor compounds and methods of use (2016-11-08),

Title: The Innovative Journey of Daniel P Sutherlin

Introduction: Daniel P Sutherlin is a renowned inventor based in San Carlos, CA (US) known for his groundbreaking contributions to various industries.

Latest Patents: Daniel P Sutherlin holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Daniel has worked with leading companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Daniel has collaborated with top researchers, engineers, and designers to bring his innovative ideas to life, resulting in successful products that have had a significant impact on society.

Conclusion: Daniel P Sutherlin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.